D. Goletti (Roma, Italy), M. Ruhwald (Copenhagen, Denmark)
Introduction: The need for better diagnostics for tuberculosis in Europe
E. Huitric (Stockholm, Sweden)
|  |
Evidence assessment on the use of IGRA testing in diagnosing active tuberculosis: A systematic TBNET review
M. Sester, G. Sotgiu, E. Girardi, C. Giehl, R. Diel, A. Bossink, K. Dheda, J. Dominguez, M. Lipman, J. Nemeth, P. Ravn, S. Winkler, E. Huitric, D. Manissero, C. Lange (Homburg, Saarbrücken, Germany; Sassari, Roma, Italy; Utrecht, Netherlands; Cape Town, South Africa; Badalona, Spain; London, United Kingdom; Basel, Switzerland; Herlev, Denmark; Vienna, Austria; Stockholm, Sweden)
|  |
Evidence assessment on the use of IGRA testing in diagnosing latent tuberculosis – A TBNET review
R. Diel, D. Cirrilo, G. Ferrara, C. Giehl, D. Goletti, E. Huitric, B. Kampmann, C. Lange, M. Losi, D. Manissero, R. Markova, G. B. Migliori, M. Ruhwald, D. Wagner, J. P. Zellweger (Saarbrücken, Germany; Milan, Terni, Rome, Modena, Tradate, Italy; Stockholm, Sweden; London, United Kingdom; Sofia, Bulgaria; Copenhagen, Denmark; Lausanne, Switzerland)
| |
Head-to-head analysis of IGRAs and skin-testing in immunocompromised patients: Interim analysis of a multicenter TBNET study
M. Sester, F. van Leth, E. Girardi, J. Bruchfeld, D. Bumbacea, O. Caliman-Sturdza, D. Cirillo, A. G. Dilektasli, J. Domínguez, R. Duarte, M. Ernst, F. Eyuboglu, I. Gerogianni, D. Goletti, J. P. Janssens, I. Julander, I. Latorre, R. Markova, A. Matteelli, G. B. Migliori, H. Milburn, P. Ravn, T. Scholman, J. Rothel, P. Soccal, M. Straub, D. Wagner, T. Wolf, A. Yalcin, C. Lange, on Behalf of TBNET (Homburg, Freiburg, Germany; The Hague, Netherlands; Roma, Milan, , Tradate, Italy; Stockholm, Sweden; Bucharest, Suceava, Romania; Ankara, Turkey; Badalona, Spain; Vila Nova de Gaia, Portugal; Thessaly, Greece; Geneva, Switzerland; Sofia, Bulgaria; London, United Kingdom; Herlev, Denmark; Carnegie, Australia)
| |
Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
|  |
The use of IGRA in investigating latent TB – A UK survey
A. S. Patel, J. Stokes, M. Shah, S. Lohani (Dartford, United Kingdom)
| |
Secondary TB risk in contacts over 35 years with IGRA positive latent tuberculosis
P. Haldar, H. Thuraisingham, G. Woltmann (Leicester, United Kingdom)
| |
Diagnosis of latent tuberculosis in children immigrants from countries with high tuberculosis prevalence
B. M. Bergamini, M. Losi, C. Del Giovane, M. Meacci, F. Luppi, C. Venturelli, R. D‘Amico, P. Spagnolo, B. Meccugni, S. Cerri, M. Codifava, F. Rumpianesi, P. Paolucci, L. M. Fabbri, L. Richeldi (Modena, Italy)
| |